Rebus Holdings, Inc. (RBSH)
OTCMKTS: RBSH · Delayed Price · USD
0.0001
0.00 (0.00%)
Apr 11, 2024, 12:00 AM EDT - Market open

Rebus Holdings Market Cap

Rebus Holdings has a market cap or net worth of $3.21 thousand as of April 16, 2024. Its market cap has decreased by -98.93% in one year.

Market Cap
3.21K
Enterprise Value
308.21K
1-Year Change
-98.93%
Ranking
n/a
Category
Stock Price
$0.00

Market Cap Chart

Since April 16, 2019, Rebus Holdings's market cap has decreased from $711.19K to $3.21K, a decrease of -99.55%. That is a compound annual growth rate of -66.10%.

History

DateMarket Cap% Change
Apr 11, 20243.21K-
Mar 14, 20243.21K-87.50%
Feb 14, 202425.71K-
Feb 13, 202425.71K-
Feb 12, 202425.71K-
Feb 9, 202425.71K-
Feb 8, 202425.71K-
Feb 7, 202425.71K-
Feb 5, 202425.71K-
Feb 2, 202425.71K-
Feb 1, 202425.71K-
Jan 30, 202425.71K-
Jan 29, 202425.71K-
Jan 26, 202425.71K-
Jan 25, 202425.71K-
Jan 24, 202425.71K-
Jan 22, 202425.71K-
Jan 19, 202425.71K-
Jan 18, 202425.71K-
Jan 17, 202425.71K-46.67%
Jan 16, 202448.20K-40.00%
Jan 12, 202480.33K-3.85%
Jan 11, 202483.55K-
Jan 10, 202483.55K-25.71%
Jan 9, 2024112.47K-33.96%
View and export this data all the way back to 2019. Sign Up Today.

Market Capitalization

Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.

Formula: Market Cap = Stock Price * Shares Outstanding
Full Definition

Related Stocks

Company Market Cap
Eli Lilly 714.63B
Novo Nordisk 555.41B
UnitedHealth Group 404.91B
Johnson & Johnson 355.34B
Merck & Co. 318.45B
AbbVie 287.34B
Thermo Fisher 215.76B
AstraZeneca 213.67B
Market Cap Rankings